DOCSLIB.ORG

ETH ZURICH Annual Report 2007 Annual Reportannual 2007 Zurich ETH ETH Zurich Annual Report 2007

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ETH ZURICH Annual Report 2007 Annual Reportannual 2007 Zurich ETH ETH Zurich Annual Report 2007 ETH Zurich Annual report 2007 ETH ZURICHETH Annual report 2007 ETH Zurich annual report 2007 Contents Donations 4 Portrait of ETH 6 Foreword from the President 8 Teaching 10 Research 12 Planning 14 ETH and industry 16 ETH and the climate 22 ETH and medicine 28 Cultural facilities 34 Picture gallery 38 Facts and figures: Highlights 40 Facts and figures 44 Honors at the ETH Day 64 Other honors for ETH staff 66 Organizational chart 73 3 Donations to ETH Zurich and the ETH Zurich Foundation Many thanks! The following companies, foundations and private individuals have given financial support to ETH Zurich and the ETH Zurich Foundation in 2007, or have promised a donation1. ETH Zurich is grateful to everyone who supports it for their valuable contributions and for their confidence. Companies GSM Association ABB Schweiz AG Hans Süsli Stiftung Ascom (Schweiz) AG Hasler Stiftung Avaloq Helmut Horten Stiftung Bühler AG HFSP Human Frontier Science Program Organization Collano AG Hirschmann-Stiftung Credit Suisse Group Zürich Holcim Foundation for Sustainable Constructions De Beers Consolidated Mines The Holcim Foundation for the Advancement Det Norske Oljeselskap AS of Scientific Research Glencore International AG International Foundation of Research in Paraplegia Gübelin AG JDRF Juvenile Diabetes Research Foundation F. Hoffmann-La Roche Ltd. Jubiläumsstiftung der Schweizerischen Mobiliar Hilti Schweiz AG Genossenschaft Johnson Matthey & Brandenberger Körber-Stiftung Mineral Consult AG Krebsliga des Kantons Zürich Novartis Pharma AG Krebsliga Zentralschweiz Omya SA Lotteriefonds des Kantons Zürich Pfizer SA Max Rössler Fonds of the Empiris Foundation Sika AG Medicor Foundation Stump ForaTec AG Mizutani Foundation for Glycoscience Swiss Re Naturstein-Verband Schweiz UBS AG NIH National Institute of Diabetes, Digestive and Zürcher Kantonalbank Kidney Diseases ZZ Wancor Novartis Institutes for Biomedical Research Novartis Stiftung Oncosuisse Organizations/Foundations OPO Stiftung Age Stiftung Präventionsstiftung der kantonalen Gebäudeversicherungen Avina Stiftung Roche Research Foundation Baugarten Stiftung SHG Stiftung für humanwissenschaftliche Bonizzi-Theler Stiftung Grundlagenforschung DFG Deutsche Forschungsgemeinschaft Stanley Medical Research Institute Eawag Staub/Kaiser-Foundation Winterthur EMBO European Molecular Biology Organization Foundation Academia Engelberg Emil Barell Stiftung Stiftung Diakoniewerk Neumünster Erdöl-Vereinigung Stiftung Professor Dr Max Cloëtta Ernst Göhner Stiftung swisselectric ESF European Science Foundation swisstopo Esperanza Medicines Foundation SWO-Stiftung Wirtschaft und Ökologie Fondation Claude & Giuliana The Rockefeller Foundation Forschungsstiftung Mobilkommunikation Velux Stiftung FWF Der Wissenschaftsfonds Verein urholz Gebert Rüf Stiftung Volkswagen Stiftung Georg und Bertha Schwyzer-Winiker Stiftung Vontobel-Stiftung GIAN – Geneva International Academic Network Wissenschaftskolleg zu Berlin Gottfried und Julia Bangerter-Rhyner Stiftung ZIL – Swiss Center for International Agriculture 4 Donations to ETH Zurich and the ETH Zurich Foundation Private individuals Christoph Menn Kurt Allemann Dr Bruno Meyer Gratian Anda Dominik Meyer Ede Andrâskay Andreas Müller Dialma J. Bänziger Tanja Müller Arnfinnur Bertelssen Lars E. Mülli Heinrich Bossert Walter Munz Frank W. Bosshart Dr Erwin Neuenschwander Walter Brauchli Rudolf Pfister Johanna Buchmann Ruedi Räss Dr Christoph Bühler Renato Reggiori Patrick Burgherr Cuno Reinhard Heinz Busenhart Dr Max Rössler Reto Caflisch Robert Rudolf Gian Carlo Dalla Vedova André J. Rotzetter Dr Martin Deuring Roger Sas Camille Diederich Peter Scartazzini Dr Peter Eckardt Milutin Scepan Ernst Fahrni Carl Schaufelberger Prof. Mario Fontana Peter Schlub Prof. Peter Fricker Dr Fritz Schnorf Kurt Funk Daniel C. Schmid Dr Armand Fürst Thomas Schmid Ulrich Graf Gianfranco Sciarini Antoine Gremaud Peter Spirig Friedrich L. Grenacher Mathias Stüssi Dr Mathis Grenacher Paolo Tamò Frank P. Gross Yves Tournier Thomas Häring Peter Trauffer Maurice Hartenbach Thomas Trüb Hans R. Holenweg Viktor Tscherry Konrad M. Huber Walter Vetsch Orhan Iskit Hans Vollenweider Reto Jenatsch Dr Ulrich Vollenweider Werner Keller Dr Branco Weiss Dr Christoph Kerez Prof. Willy Wilk Georg Kern Hansjakob Windler Waldemar Kieliger Maximilian Winkler Peter Knoblauch Dr Willy Wüthrich Dr André Lambert Alfeo Zanetti Prof. Hans-Jürgen Lang Dr Walter Ziegler Emil Lanker Walter Zundel Aleardo Lombardi Marc Luedi Peter Lüthi 1 This list includes all donations known Anita Lutz to ETH transfer and the ETH Zurich Foundation. 5 Portrait of ETH ETH Zurich ETH Zurich stands for world-class scientific expertise, research that benefits industry and society and the education of highly qualified specialists. As a globally leading technical and scientific university, ETH Zurich opens up wide and diverse horizons to students of natural sciences and engineering. Furthermore, as a premier international research university, it also provides a stimulating environment for top-flight research. The university’s outstanding reputation is confirmed by the fact that no fewer than 21 Nobel Prize Laureates have studied, taught or carried out their research here. Now, with the Science City campus project, ETH Zurich is helping to develop Zurich into a lively knowledge hub. Its long-established partnerships with industry, its location in the heart of Europe and its relationships with other world-class universities and research institutions combine to foster a unique regional and networked knowledge environment that is rooted in the multilingual and rich cultural tradition of Switzerland. 6 Foreword from the President A combination of large and small Dear Reader, It is something we often observe in business: small and areas of research such as neurosciences and environmen- medium-sized enterprises can operate more flexibly than tal risk research, greatly strengthening Zurich’s importance large international companies. By contrast, major corpora- as a knowledge hub. tions have the critical mass and also the financial resour- ces that small and medium-sized enterprises (SME) lack to New faces on the Executive Board undertake large-scale projects. In its academic endeavors, The unsettled and politically turbulent time that followed ETH Zurich tries to combine both approaches and to be not the resignation of former President Ernst Hafen in Novem- only flexible but also effective. To this end, it offers indi- ber 2006 is now over. With Konrad Osterwalder, who took vidual professorships on the one hand, for tackling the on the demanding dual role of interim President and Rec- unimaginable and the fundamental, and on the other hand tor until his retirement at the end of August 2007, the af- various networks of competence that attempt to find so- fairs of ETH were in capable hands. He has now been given lutions to complex problems. the honor of becoming President of the UN University in Tokyo. Since September, ETH has once again had a full Award-winning research groups executive team, including three new faces: President Ralph The honors awarded this year to outstanding scientists are Eichler (a physicist), Rector Heidi Wunderli-Allenspach good examples of the successes of individual professor- (a biologist) and Peter Chen (a chemist), Vice President Re- ships. Particularly worthy of note are Professor Peter See- search and Business Relations. Gerhard Schmitt (an archi- berger, who won the renowned Körber Prize, and Professor tect) was already part of the previous board as Vice Presi- Ari Helenius, who won the Marcel Benoist Prize, the “Swiss dent Planning and Logistics. Nobel Prize”. Both scientists have achieved remarkable re- Student numbers have risen again. It is particularly pleas- sults with their groups. Another excellent performance ing to see a reversal in the decline in numbers of engineers, was that of our student team at the International Micro especially the increase in mechanical and process engi- Robot Maze Contest in the USA, where they won first neers. Nevertheless, industry still requires many more such prize. A larger network of competence is the Department highly qualified professionals from ETH. That is why efforts of Environmental Sciences, which was founded 20 years to encourage schoolchildren to go on to study engineering ago. At a small ceremony, the speakers paid tribute to the or natural sciences continue to be a high priority. department’s achievements in education and networked research. The contribution made by ETH to the IPCC report Record 21 spin-offs founded on the highly complex subject of climate change is also Not all ETH graduates wish to stay in academic research or noteworthy, with the climate researchers who worked on use their knowledge in an existing company. A growing it being awarded the Nobel Peace Prize. Striking the right number of them are interested in setting up their own balance between supporting individual projects and the companies. Last year we set a new record with 21 compa- theme-based networks was and remains the long-term nies being established. All these young entrepreneurs re- duty of the ETH Executive Board. ceive professional assistance from experienced people from the world of business, who make their expertise Pooling expertise available to help produce an effective business plan. For Research is increasingly networked and responds to global- the first two years, spin-offs can rent premises at ETH, so ization. This is why the newly established competence as to be able to
Load more

Recommended publications
  • Symposium ”Diabetes - a Threat to Mankind”
    Symposium ”Diabetes - a Threat to Mankind” 7-8 June, 2013 in Helsinki, Finland The Finnish Diabetic Nephropathy Study Folkhälsan Institute of Genetics, Folkhälsan Research Center Biomedicum Helsinki 1, room C318 Haartmaninkatu 8 FI- 00290, Helsinki www.finndiane.fi Local Organizing Committee Per-Henrik Groop [email protected] tel. +358 9 191 25459 Carol Forsblom [email protected] tel. +358 40 5559556 Asta Mustonen [email protected] tel. +358 44 7883743 Maikki Parkkonen [email protected] tel. +358 9 19125387 Dear Participants, It is my great pleasure and honor to welcome you all to the “Diabetes – A Threat to Mankind” symposium held in Helsinki on June 7-8, 2013. This symposium will include presentations by a roster of award winning keynote speakers exploring both type 1 and type 2 diabetes and cover- ing topics ranging from disease pathogenesis to diabetic complications. This symposium was made possible by an unrestricted educational grant from the Wilhelm and Else Stockmann Foundation. Established in 1953 with the goal of promoting research that aims to prevent or ease the suffering caused by common complex diseases, the Wilhelm and Else Stockmann Foundation has played a major role in supporting dia- betes research in Finland. This symposium will serve to highlight both the 60th anniversary of the Foundation as well as the 15th Anniversary of the Finnish Diabetic Nephropathy Study. My sincere thanks go to all invited speakers and chairmen who, de- spite their busy schedules all agreed to come to Helsinki to share their knowledge and expertise with us. I am also indebted to all of you who accepted the invitation to take part in this event.
    [Show full text]
  • EASD2020 Finalprogramme.Pdf
    56TH ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES Content Page EASD . 4 Morgagni Prize . 10 General Information . 12 EASD Community Plaza . 15 Programme at a Glance . 20 EASD e-Learning . 28 European Diabetes Forum (EUDF) . 29 EFSD Mentorship Programme . 30 Tuesday, 22 September . 32 Claude Bernard Lecture . 32 Poster Event A . 41 Poster Event B . 42 Camillo Golgi Lecture . 50 Albert Renold Lecture . 52 Wednesday, 23 September . 54 Poster Event C . 64 Poster Event D . 65 Diabetes Prize for Excellence Lecture . 72 Thursday, 24 September . 77 Rising Star Symposium . 80 Poster Event E . 90 Poster Event F . 91 Minkowski Lecture . 98 Friday, 25 September . 102 Posters . 119 Index of Presenting Authors . 230 Index of Symposium Speakers . 242 European Foundation for the Study of Diabetes (EFSD) . 244 Symposia on the occasion of the 56th EASD Annual Meeting . 248 Industry Symposia and Meet the Expert Sessions on the occasion of the 56th EASD Annual Meeting (organised by INTERPLAN) . 263 57th EASD Annual Meeting . 310 DEAR MEMBERS AND GUESTS, It is my great honour and pleasure to welcome you to the 56th Annual Meeting of the European Association for the Study of Diabetes, which will take place – due to the severe global impact of the COVID-19 pandemic – as an innovative Virtual Meeting from 21 to 25 September 2020. EASD We have developed a virtual experience using the latest technology to connect the global diabetes community, share ground-breaking diabetes science and research, and to provide educational opportunities that
    [Show full text]
  • KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
    98 4S SUPPLEMENT TO kidney international kidney INTERNATIONAL volume 98volume issue 4S October 2020 KDIGO 2020 Clinical Practice Guideline for pages S1–S116 Diabetes Management in Chronic Kidney Disease VOLUME 98 | ISSUE 4S | OCTOBER 2020 www.kidney-international.org KKINT_v98_i4_sS_COVER.inddINT_v98_i4_sS_COVER.indd 1 99/26/2020/26/2020 110:05:330:05:33 PPMM ASSOCIATE EDITORS P. Toby Coates, Adelaide Transplant and Immunology Olivier Devuyst, Zurich Physiology, Genetics, Kidney Cancer Tilman B. Drueke, Paris CKD, Hypertension, Nephrolithiasis EDITOR NEPHROLOGY DIGEST EDITOR Jürgen Floege, Aachen Pierre Ronco, Paris Christina Wyatt, New York Glomerulonephritis, CKD-MBD Clinical Investigation Agnes B. Fogo, Nashville Clinical and Experimental Renal Pathology STATISTICIANS DEPUTY EDITOR T. Alp Ikizler, Nashville Vic Hasselblad, Jacksonville Dialysis, Acute Kidney Injury, Nutrition, Metabolism Brad Rovin, Columbus Zhezhen Jin, New York Masaomi Nangaku, Tokyo Translational Nephrology Joseph Kim, Toronto Clinical and Experimental CKD Yi-Ju Li, Durham and Diabetic Kidney Disease Dorothea Nitsch, PAST EDITORS London Jai Radhakrishnan, New York Rajasekhar Ramakrishnan, New York Detlef Schlöndorff, New York Editor KIR, Clinical Studies, Images in Nephrology, Qais Al-Awqati, New York Make Your Diagnosis Saulo Klahr, St. Louis KI FELLOWSHIP INTERNS Germaine Wong, Sydney Thomas E. Andreoli, Little Rock Anna Francis, Brisbane Life Course Epidemiology, Health Economics Roscoe R. Robinson, Durham Sethu Madhavan, Columbus and Onconephrology EDITORIAL BOARD Anupam Agarwal, Birmingham Michelle Hladunewich, Toronto Mark Okusa, Charlottesville Evren Azeloglu, New York Fan Fan Hou, Guangzhou Juan Oliver, New York Sean Barbour, Vancouver Pascal Houillier, Paris Cristian Pattaro, Bolzano Jonathan Barratt, Leicester Chi-yuan Hsu, San Francisco Aldo Peixoto, West Haven David Basile, Indianapolis Tobias B.
    [Show full text]
  • Curriculum Vitae Miriam Cnop
    Curriculum vitae Miriam Cnop CURRICULUM VITAE Miriam Cnop, MD, PhD ADDRESS Home: Boudewijnlaan 21 1700 Dilbeek, Belgium Phone 32.2.270.37.79 Work: Division of Endocrinology, Department of Medicine, Erasmus Hospital and ULB Center for Diabetes Research, Faculty of Medicine Université Libre de Bruxelles 808, Route de Lennik 1070 Brussels, Belgium Phone 32.2.555.63.05 Fax 32.2.555.62.39 [email protected] DATE AND PLACE OF BIRTH December 25, 1970, Elsene, Belgium NATIONALITY Belgian LANGUAGES Dutch (mother tongue), English (fluent), French (fluent), German (basic), Portuguese (basic) EDUCATION HIGH SCHOOL 1982-1988 Orientation Latin/Mathematics, Royal Atheneum Tervuren, Belgium UNIVERSITY Graduate Vrije Universiteit Brussel, Brussels, Belgium 1988-1995 Medical Doctor Summa cum Laude Magna cum Laude Magna cum Laude Magna cum Laude Summa cum Laude Summa cum Laude Summa cum Laude First Prize of the Faculty Jury for the Best Medical Curriculum Graduate thesis: ‘Effects of lipids on rat pancreatic cells’, Diabetes Research Center, Vrije Universiteit Brussel (Supervisor Prof D Pipeleers) Post-graduate 1 Curriculum vitae Miriam Cnop 1995-2002 PhD program, Faculty of Medicine, Vrije Universiteit Brussel, Brussels, Belgium (Supervisor Prof Daniel Pipeleers) Supported by a scholarship of the Belgian Fund for Scientific Research (Aspirant FWO) Title of the PhD thesis ‘Lipids, putative cell pathogens in type 2 diabetes’ (date of defense: May 2002) 1995-2001 Specialization in Internal Medicine, Vrije Universiteit Brussel, Belgium 2000-2001 Post-doctoral
    [Show full text]
  • BIOGRAPHICAL SKETCH NAME: Johan AUWERX, M.D., Ph.D. Era
    OMB No. 0925-0001 and 0925-0002 (Rev. 03/2020 Approved Through 02/28/2023) BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors. Follow this format for each person. DO NOT EXCEED FIVE PAGES. NAME: Johan AUWERX, M.D., Ph.D. eRA COMMONS USER NAME (credential, e.g., agency login): AUWERX POSITION TITLE: Professor at the Ecole Polytechnique Fédérale Lausanne (EPFL), Switzerland EDUCATION/TRAINING COMPLETI INSTITUTION AND LOCATION DEGREE FIELD OF STUDY ON DATE Catholic University of Leuven, Leuven, Belgium B.S. 1979 Biochemistry & Genetics Catholic University of Leuven, Leuven, Belgium M.D. 1982 Medicine Catholic University of Leuven, Leuven, Belgium Resident 1982-1986 Intern. Med/Endocrinology Catholic University of Leuven, Leuven, Belgium Ph.D. 1990 Molecular Endocrinology University of Washington, Seattle, WA Post-doc 1986-1988 Molecular Endocrinology ECFMG / VQE M.D. 1982 A. Personal Statement I am trained as a physician scientist and have extensive research expertise and experience in cellular and molecular physiology, metabolism, and genetics developed in C. elegans, mice, and humans. I have been using systems approaches to map the signaling networks that coordinate the communication between the nucleus and the mitochondria and as such regulate organismal metabolism in health, aging, and disease. Although my research has addressed basic biomedical questions, my medical background facilitated the translation of his research into novel preventive and therapeutic strategies for common age-related diseases, such as type 2 diabetes, obesity, atherosclerosis, and frailty, as well as for rare inherited mitochondrial diseases. The translational value of my work is testified by the fact that several drugs targeting processes and pathways, which I elucidated are currently used in the clinic.
    [Show full text]
  • EASD FP 19 Gesamt Internet.Pdf
    Umschlag_fp_19_Internet.qxp_Layout 1 02.07.19 13:02 Seite 1 Umschlag_fp_19_Internet.qxp_Layout 1 02.07.19 13:02 Seite 2 55TH ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES Content Page EASD . 4 General Information . 10 EASD Community Plaza . 14 Programme at a Glance . 22 EASD e-Learning . 30 EFSD Mentorship Programme . 31 EUDF Symposia . 32 Tuesday, 17 September . 34 Claude Bernard Lecture . 34 Poster Event A . 45 Poster Event B . 48 Camillo Golgi Lecture . 56 Albert Renold Lecture . 58 Rising Star Symposium . 60 Wednesday, 18 September . 62 Poster Event C . 74 Poster Event D . 77 Diabetes Prize for Excellence Lecture . 84 Thursday, 19 September . 89 Poster Event E . 100 Poster Event F . 103 Minkowski Lecture . 110 Friday, 20 September . 114 Posters . 131 Index of Presenting Authors . 264 Index of Symposium Speakers . 279 European Foundation for the Study of Diabetes (EFSD) . 281 Symposia on the occasion of the 55th EASD Annual Meeting . 285 Industry Symposia, Meet the Expert Sessions and Exhibition on the occasion of the 55th EASD Annual Meeting (organised by INTERPLAN) . 293 56th EASD Annual Meeting . 324 DEAR MEMBERS AND GUESTS, It will be my great honour and pleasure to welcome you to the 55th Annual Meeting of the European Association for the Study of Diabetes e.V. which will take place in Barcelona from 16 to 20 September 2019. EASD Under the chairmanship of EASD Honorary Secretary, Mikael Rydén, the Scientific Programme Committee selected 1195 abstracts for presentation from a total of 2003 submitted. The outstanding programme will comprise of stimulating symposia, numerous oral and poster presentations as well as Prize Lectures, honouring the achievements of distinguished researchers.
    [Show full text]
  • Michael Berger, in Memoriam 02.06
    EASD EASD EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES ASSOCIATION EUROPEENE POUR L’ETUDE DU DIABETE · EUROPÄISCHE GESELLSCHAFT FÜR DIABETOLOGIE News Section Rheindorfer Weg 3 · D-40591 Düsseldorf · Germany · Tel: +49-211-7 58 46 90 · Fax: +49-211-75 84 69 29 10/2002 E-mail: [email protected] · Homepage: http://www.easd.org Michael Berger, in memoriam 02.06. 1944–18.08.2002 Balodimos Award, New England Diabetes Associa- tion, Boston, USA (1973); the Ferdinand Bertram Award, German Diabetes Association (1978); the Kellion Award, Australian Diabetes Association (1982); the Arnold Durig Award, Austrian Association for Nu- trition (1982); Louis-Pasteur Medal, ALFEDIAM (1988); the Albert Renold Medal, European Associa- tion for the Study of Diabetes (1980); the 1993 Medal of Honour, Faculty of Medicine, Sofia University, Bulgaria (1993); the Mizuno Award Osaka, Japan (1993); and the Claude Bernard Lecturer of EASD (1995). Michael Berger became honorary member of the following associations: Union de Travailleurs Sci- entifique, Bulgaria (1977); Diabetes Association of Argentina (1984); Diabetes Association of Paraguay (1984); Rumanian Association for Nutrition and Met- Professor Michael Berger, former President of EASD abolic Diseases (1985); Association for Diabetes and and Editor-in-Chief of Diabetologia, died in Düssel- Nutrition of Uruguay (1990); Bulgarian Association dorf on 18 August 2002, following a long and severe for Internal Medicine (1993); Hungarian Diabetes illness which he bore with courage and dignity. Born Association (1994). He was Guest Professor of Inter- in Schmalkalden, Thüringen, Germany on 2 June nal Medicine, University of Benghazi, Libya (1983); 1944, Michael Berger went to medical school from Honorary President, Diabetes Association of Ecuador 1963-1969 at the universities of Würzburg/Germany, (1986) and a Member of the Academy of Medicine of Galway/Ireland and Düsseldorf/Germany and received Romania (1994).
    [Show full text]
  • Outputs, Outcomes and Impact of MRC Research 2014/15 Report
    Outputs, outcomes and impact of MRC research 2014/15 report European Union (EU) Scale: 1 Collaboration ISBN 978-0-903730-22-8 © Medical Research Council copyright 2016 You may re-use this information (excluding logos, images and icons) free of charge in any format or medium, under the terms of the Open Government Licence. To view this licence, visit http://www.nationalarchives.gov.uk/doc/open-government-licence/ or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or e-mail: [email protected] When providing a citation for this document we recommend the following: Medical Research Council (2016) MRC Outputs, outcomes and impact of MRC research 2014/15 report. Publisher: Medical Research Council, London, UK. ISBN: 978-0-903730-22-8 Any enquiries related to this publication should be sent to us at: Medical Research Council, 14th Floor, One Kemble Street, London WC2B 4AN or [email protected] This publication is available at https://www.mrc.ac.uk/successes/outputs-report/ Table of Contents List of case studies by primary output type 3 SECTION 1.0: Introduction 7 Overview 9 Key 11 researchfish® 12 SECTION 2.0: Case studies 15 2.1: Published research 17 2.2: Policy and engagement 37 2.3: Development of products and intellectual property 65 2.4: Research materials 107 2.5: Industry interactions and other collaborations 135 2.6: Awards and recognition 165 SECTION 3: Quantitative analysis 179 3.1 Publications 181 3.2: Collaborations 186 3.3 Further funding 191 3.4 Next destination 198 3.5 Engagement activities 201 3.6 Influence on policy 205 3.7 Research materials – tools and methods, databases and models 210 3.8 Intellectual property 215 3.9 Products and interventions 219 3.10 Awards and recognition 225 Front cover image credits Mosquito on human skin at sunset.
    [Show full text]
  • FINAL PROGRAMME Programme Final Fp1 2013__ 15.08.13 10:32 Seite 2
    Title_Final_prog2013__ 15.08.13 10:51 Seite 1 Final Programme EASD 2013 FINAL BARCELONA PROGRAMME fp1_2013__ 15.08.13 10:32 Seite 2 49th annual meeting oF the euroPean association For the study oF diabetes scientific Programme Page European Foundation for the Study of Diabetes 10 General Information 14 Map of the Conference Centre 22 Programme at a Glance 24 Monday, 23 September 34 EASD App 35 Tuesday, 24 September 36 Opening Ceremony 37 Minkowski Lecture 37 Poster Event A and B 45 Camillo Golgi Lecture 55 Albert Renold Lecture 57 Rising Star Symposium 58 Wednesday, 25 September 60 Poster Event C and D 69 Thursday, 26 September 82 Poster Event E and F 91 EASD General Assembly 102 Friday, 27 September 104 Claude Bernard Lecture 119 Closing Ceremony 120 Posters 121 Index of Presenting Authors 276 Index of Invited Speakers 293 50th Annual Meeting 296 2 fp1_2013__ 15.08.13 10:32 Seite 3 dear members, dear guests, From 23 to 27 september it will be my great honour and pleasure to welcome you to the 49th easd annual meeting. under the outstanding chairmanship of our honorary secretary, Prof. mark Walker, the scientific Programme committee has selected 1361 from a total of 2321 submitted abstracts for presentation this year. the scientific Programme comprises six parallel tracks which include inspiring symposia, keynote lectures and debates covering basic and clinical science. the scientific Programme reflects the ongoing efforts to understand, cure and prevent diabetes. our main hall is named after claude bernard in order to celebrate his 200th birthday. 30 years ago saw the inception and planning of the dcct, and the final results of the uKPds were presented at the 34th easd annual meeting in barcelona.
    [Show full text]
  • EASD2021-Final Programme
    FINAL PROGRAMME 57TH ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES Content Page EASD . 4 General Information . 10 EASD Community Plaza . 15 Programme at a Glance . 20 Ask the EASD e-Learning Expert Sessions . 28 EFSD Mentorship Programme . 30 EUDF Symposium . 31 Tuesday, 28 September . 32 Claude Bernard Lecture . 32 Short Oral Discussion Event A . 41 Short Oral Discussion Event B . 42 Camillo Golgi Lecture . 50 Albert Renold Lecture . 52 Rising Star Symposium . 54 Wednesday, 29 September . 56 Short Oral Discussion Event C . 66 Short Oral Discussion Event D . 67 Diabetes Prize for Excellence Lecture . 74 Thursday, 30 September . 80 Short Oral Discussion Event E . 92 Short Oral Discussion Event F . 93 Minkowski Lecture . 100 Friday, 1 October . 106 Short Orals . 127 Index of Presenting Authors . 196 Index of Symposium Speakers . 206 European Foundation for the Study of Diabetes (EFSD) . 208 Symposia on the occasion of the 57th EASD Annual Meeting . 212 Industry Symposia and Meet the Expert Sessions on the occasion of the 57th EASD Annual Meeting (organised by INTERPLAN) . 227 58th EASD Annual Meeting . 302 DEAR MEMBERS AND GUESTS, It will be my great honour and pleasure to welcome you to the 57th Annual Meeting of the European Association for the Study of Diabetes, which will take place from 27 September to 1 October 2021. Due to the ongoing global impact of the COVID-19 EASD pandemic, and the continued uncertainty regarding travel, events, public gatherings and public health, we have decided to run the EASD Annual Meeting in 2021 again as an online event.
    [Show full text]
  • CV Jens Claus Brüning
    CURRICULUM VITAE Name: Jens Claus Brüning, Professor, M.D. Date and place of birth: June 4th, 1966, Cologne, Germany Address: Max Planck Institute for Metabolism Research Gleueler Str. 50 50931 Cologne, Germany Phone: +49-(0) 221 4726 202 Fax: +49-(0) 221 4726 203 E-mail: [email protected] Policlinic for Endocrinology, Diabetes and Preventive Medicine University Hospital Cologne Kerpener Str. 62 50937 Cologne, Germany Phone: +49 (0) 221 478-4070 Fax: +49 (0) 221 478-4179 E-mail: [email protected] UNIVERSITY EDUCATION 1993 Medical doctoral degree, University of Cologne, Germany 1985-1992 Medical School, University of Cologne, Germany ACADEMIC APPOINTMENT AND RESEARCH EXPERIENCE 8/2018-12/2018 Visiting Miller Professor, University of California/Berkeley, Department of Molecular and Cell Biology, CA, USA 5/2014-present Tenured Professor at the Medical Faculty, University of Cologne 3/2013-present Visiting Professor, Department of Comparative Medicine, Yale University, New Haven, USA 2/2011-present Director of the Max Planck Institute for Metabolism Research, Cologne, Germany (former Max Planck Institute for Neurological Research) 2/2011-present Director of the Policlinic for Endocrinology, Diabetes and Preventive Medicine (PEDP) at the University Hospital of Cologne, Germany 1/2009-12/2011 Max-Planck Fellow of the Max Planck Institute for the Biology of Ageing, Cologne, Germany 11/2007-1/2019 Founding Director and Coordinator of the Cologne Excellence Cluster “Cellular stress responses in aging-associated diseases (CECAD)”, University
    [Show full text]
  • EFSD Applicant Report
    FUNDING DIABETES RESEARCH SINCE 2000 For Potential Grant Applicants European Foundation EFSD for the Study of Diabetes European Foundation EFSD for the Study of Diabetes FUNDING DIABETES RESEARCH SINCE 2000 Foreword EFSD operates on a strictly non-profit basis of the researchers that we have funded over working tirelessly in association with many the years. It is an opportunity for us all to reflect of the world’s leadingGRANTS pharmaceutical and & FELLOWSHIPSon our progress and how you have helped us biotechnology companies to offer an array with our mission to enhance awareness of of different funding streams to young and the severity of diabetes and the magnitude establishedAVAILABLE researchers alike. THROUGHOUTof this devastating THE disease YEAR across Europe. Over the years, our successful fundraising It is only through research that we can do this. President: Stefano Del Prato, Italy strategy has allowed us to commit in excess As we move forwards, our goal is to continue of 100 million Euros to diabetes research and to partner with as many companies and Chairman: Michael Roden, Germany we havewww.EuropeanDiabetesFoundation.org grown to become one of the most organisations as we can to ensure that we significant funding agencies for diabetes offer new funding streams that are as relevant Members of the EFSD Scientific Board: research in Europe. As we look back on what to today’s research needs and that attract Tadej Battelino, Slovenia Paola Fioretto, Italy we have achieved, we are heartened to see the very best grant applications as they were Matthias Blüher, Germany Hasan Al-Hasani, Germany the impact that our funding has had.
    [Show full text]